Melissa Baird - 27 Dec 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
27 Dec 2024
Net transactions value
+$143,669
Form type
4
Filing time
30 Dec 2024, 16:22:59 UTC
Previous filing
17 Dec 2024
Next filing
23 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $130,260 +26,000 +3.8% $5.01 701,354 27 Dec 2024 Direct
transaction HIMS Class A Common Stock Options Exercise $13,409 +5,518 +0.79% $2.43 706,872 27 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -26,000 -1.6% $0.000000 1,635,128 27 Dec 2024 Class A Common Stock 26,000 $5.01 Direct F1
transaction HIMS Stock Option (right to buy) Options Exercise $0 -5,518 -0.74% $0.000000 737,894 27 Dec 2024 Class A Common Stock 5,518 $2.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
F2 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.